AQUANOMIC SOLID NEUTRA-PLUS

Primær information

  • Handelsnavn:
  • AQUANOMIC SOLID NEUTRA-PLUS
  • Brugt til:
  • Mennesker
  • Medicin typen:
  • Medicinsk udstyr

Dokumenter

  • for den brede offentlighed:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for offentligheden.

  • for sundhedspersonale:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for sundhedspersonale.

Lokation

  • Fås i:
  • AQUANOMIC SOLID NEUTRA-PLUS
    Danmark
  • Sprog:
  • dansk

Andre oplysninger

Status

  • Kilde:
  • Ecolab
  • Autorisationsnummer:
  • 116798E
  • Sidste ændring:
  • 12-03-2018
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.

    Anmode informationsbrochure for offentligheden.

17-7-2017

Orphan designation:  Murine IgM monoclonal antibody binding to alpha beta T-cell receptor,  for the: Prevention of graft rejection following solid organ transplantation

Orphan designation: Murine IgM monoclonal antibody binding to alpha beta T-cell receptor, for the: Prevention of graft rejection following solid organ transplantation

On 12 March 2013, orphan designation (EU/3/13/1113) was granted by the European Commission to CTI Clinical Trial and Consulting Services, Germany, for murine IgM monoclonal antibody binding to alpha beta T-cell receptor for the prevention of graft rejection following solid organ transplantation.

Europe - EMA - European Medicines Agency

3-7-2017

FDA clears expanded use of cooling cap to reduce hair loss during chemotherapy

FDA clears expanded use of cooling cap to reduce hair loss during chemotherapy

Today, the U.S. Food and Drug Administration cleared the expanded use of a cooling cap, DigniCap Cooling System, to reduce hair loss (alopecia) during chemotherapy. This is the first cooling cap cleared by the agency for use in cancer patients with solid tumors.

FDA - U.S. Food and Drug Administration

23-5-2017

FDA approves first cancer treatment for any solid tumor with a specific genetic feature

FDA approves first cancer treatment for any solid tumor with a specific genetic feature

The U.S. Food and Drug Administration today granted accelerated approval to a treatment for patients whose cancers have a specific genetic feature (biomarker). This is the first time the agency has approved a cancer treatment based on a common biomarker rather than the location in the body where the tumor originated

FDA - U.S. Food and Drug Administration

5-1-2018

Most U.S. Babies Start Solid Foods Too Soon

Most U.S. Babies Start Solid Foods Too Soon

Title: Most U.S. Babies Start Solid Foods Too SoonCategory: Health NewsCreated: 1/4/2018 12:00:00 AMLast Editorial Review: 1/4/2018 12:00:00 AM

US - MedicineNet

28-12-2017

CERTAIN DRI SOLID (Aluminum Sesquichlorohydrate) Stick [Clarion Brands, LLC]

CERTAIN DRI SOLID (Aluminum Sesquichlorohydrate) Stick [Clarion Brands, LLC]

Updated Date: Dec 28, 2017 EST

US - DailyMed

3-7-2017

FDA Expands Use of Cooling Cap to Reduce Hair Loss During Chemotherapy

FDA Expands Use of Cooling Cap to Reduce Hair Loss During Chemotherapy

Today, the U.S. Food and Drug Administration cleared the expanded use of a cooling cap, DigniCap Cooling System, to reduce hair loss (alopecia) during chemotherapy. This is the first cooling cap cleared by the agency for use in cancer patients with solid tumors.

US - RxList